Lower Urinary Tract Symptoms, Depression, Anxiety and Systemic Inflammatory Factors in Men: A Population-Based Cohort Study

Sean Martin, Andrew Vincent, Anne W Taylor, Evan Atlantis, Alicia Jenkins, Andrzej Januszewski, Peter O'Loughlin, Gary Wittert, Sean Martin, Andrew Vincent, Anne W Taylor, Evan Atlantis, Alicia Jenkins, Andrzej Januszewski, Peter O'Loughlin, Gary Wittert

Abstract

Background: The relationship between lower urinary tract symptoms (LUTS) and common mental health disorders such as depression and anxiety in men remains unclear. Inflammation has recently been identified as an independent risk factor for LUTS and depression. This study aimed to assess the association between depression, anxiety and LUTS, and the moderating influence of systemic inflammation, in the presence of other biopsychosocial confounders.

Methods: Participants were randomly-selected from urban, community-dwelling males aged 35-80 years at recruitment (n = 1195; sample response rate:67.8%). Of these, 730 men who attended baseline (2002-5) and follow-up clinic visits (2007-10), with complete outcome measures, and without prostate or bladder cancer and/or surgery, neurodegenerative conditions, or antipsychotic medications use, were selected for the present study. Unadjusted and multi-adjusted regression models of incident storage and voiding LUTS and incident depression and anxiety were combined with serum inflammatory markers (high-sensitive C-reactive protein (hsCRP), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), myeloperoxidase (MPO), soluble e-selectin (e-Sel)) and socio-demographic, lifestyle, and health-related factors. Hierarchical multiple regression was used to assessed the moderating effect of inflammatory markers.

Results: The incidence of storage, voiding LUTS, depression and anxiety was 16.3% (n = 108), 12.1% (n = 88), 14.5% (n = 108), and 12.2% (n = 107). Regression models demonstrated that men with depression and anxiety at baseline were more likely to have incident storage, but not voiding LUTS (OR: 1.26, 99%CI: 1.01-4.02; and OR:1.74; 99%CI:1.05-2.21, respectively). Men with anxiety and storage LUTS at baseline were more likely to have incident depression (OR: 2.77, 99%CI: 1.65-7.89; and OR:1.45; 99%CI:1.05-2.36, respectively), while men with depression and voiding LUTS were more likely to have anxiety at follow-up (OR: 5.06, 99%CI: 2.81-9.11; and OR:2.40; 99%CI:1.16-4.98, respectively). CRP, TNF-α, and e-Sel were found to have significant moderating effects on the development of storage LUTS (1.06, 0.91-1.96, R2 change: 12.7%), depression (1.17, 1.01-1.54, R2 change: 9.8%), and anxiety (1.35, 1.03-1.76, R2 change: 10.6%), respectively.

Conclusions: There is a bidirectional relationship between storage, but not voiding, LUTS and both depression and anxiety. We observed variable moderation effects for selected inflammatory markers on the development of depression, anxiety and storage LUTS.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Consort diagrams for the final…
Fig 1. Consort diagrams for the final analytical samples for incident storage, voiding LUTS, depression and anxiety in a community cohort of Australian men.

References

    1. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108(7):1132–8. Epub 2011/01/15. 10.1111/j.1464-410X.2010.09993.x .
    1. Robertson C, Link CL, Onel E, Mazzetta C, Keech M, Hobbs R, et al. The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies. BJU Int. 2007;99(2):347–54. Epub 2007/02/23. doi: BJU6609 [pii] 10.1111/j.1464-410X.2007.06609.x .
    1. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS medicine. 2013;10(11):e1001547 Epub 2013/11/14. 10.1371/journal.pmed.1001547
    1. Chapple CR, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, et al. Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol. 2008;54(3):563–9. Epub 2008/04/22. doi: S0302-2838(08)00419-3 [pii] 10.1016/j.eururo.2008.03.109 .
    1. Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012;80(1):90–6. Epub 2012/07/04. doi: S0090-4295(12)00386-X [pii] 10.1016/j.urology.2012.04.004 .
    1. Chung RY, Leung JC, Chan DC, Woo J, Wong CK, Wong SY. Lower urinary tract symptoms (LUTS) as a risk factor for depressive symptoms in elderly men: results from a large prospective study in Southern Chinese men. PLoS ONE. 2013;8(9):e76017 Epub 2013/10/08. 10.1371/journal.pone.0076017
    1. Kupelian V, McVary KT, Kaplan SA, Hall SA, Link CL, Aiyer LP, et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. J Urol. 2009;182(2):616–24; discussion 24–5. Epub 2009/06/23. doi: S0022-5347(09)00934-3 [pii] 10.1016/j.juro.2009.04.025 .
    1. Hung SF, Chung SD, Kuo HC. Increased serum C-reactive protein level is associated with increased storage lower urinary tract symptoms in men with benign prostatic hyperplasia. PLoS ONE. 2014;9(1):e85588 Epub 2014/01/24. 10.1371/journal.pone.0085588
    1. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic brain disease. 2009;24(1):27–53. Epub 2008/12/17. 10.1007/s11011-008-9118-1 .
    1. Martin S, Haren M, Taylor A, Middleton S, Wittert G. Cohort profile: the Florey Adelaide Male Ageing Study (FAMAS). Int J Epidemiol. 2007;36(2):302–6. Epub 2007/01/16. doi: dyl279 [pii] 10.1093/ije/dyl279 .
    1. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57; discussion 64. Epub 1992/11/11. .
    1. Beck AT, Beck RW. Screening depressed patients in family practice. A rapid technic. Postgrad Med. 1972;52(6):81–5. Epub 1972/12/01. .
    1. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD–7. Arch Intern Med. 2006;166(10):1092–7. Epub 2006/05/24. 10.1001/archinte.166.10.1092 .
    1. Coyne KS, Kvasz M, Ireland AM, Milsom I, Kopp ZS, Chapple CR. Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol. 2012;61(1):88–95. Epub 2011/08/13. 10.1016/j.eururo.2011.07.049 .
    1. Breyer BN, Kenfield SA, Blaschko SD, Erickson BA. The association of lower urinary tract symptoms, depression and suicidal ideation: data from the 2005–2006 and 2007–2008 National Health and Nutrition Examination Survey. J Urol. 2014;191(5):1333–9. Epub 2013/12/18. 10.1016/j.juro.2013.12.012
    1. Coyne KS, Matza LS, Kopp ZS, Thompson C, Henry D, Irwin DE, et al. Examining lower urinary tract symptom constellations using cluster analysis. BJU Int. 2008;101(10):1267–73. Epub 2008/03/14. doi: BJU7598 [pii] 10.1111/j.1464-410X.2008.07598.x .
    1. Lee YI, Kim JW, Bae SR, Paick SH, Kim KW, Kim HG, et al. Effect of urgency symptoms on the risk of depression in community-dwelling elderly men. Korean journal of urology. 2013;54(11):762–6. Epub 2013/11/21. 10.4111/kju.2013.54.11.762
    1. Huang CY, Chiu KM, Chung SD, Keller JJ, Huang CC, Lin HC. Increased risk of depressive disorder following the diagnosis of benign prostatic enlargement: one-year follow-up study. J Affect Disord. 2011;135(1–3):395–9. Epub 2011/08/10. 10.1016/j.jad.2011.07.001 .
    1. Wong SY, Woo J, Leung JC, Leung PC. Depressive symptoms and lifestyle factors as risk factors of lower urinary tract symptoms in Southern Chinese men: a prospective study. Aging Male. 2010;13(2):113–9. Epub 2010/05/01. 10.3109/13685530903440432 .
    1. Punnen S, Cowan JE, Dunn LB, Shumay DM, Carroll PR, Cooperberg MR. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. BJU Int. 2013;112(2):E67–75. Epub 2013/06/26. 10.1111/bju.12209 .
    1. Martin SA, Haren MT, Marshall VR, Lange K, Wittert GA. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol. 2011;29(2):179–84. Epub 2010/10/22. 10.1007/s00345-010-0605-8 .
    1. Latz I, Weber M, Korda R, Smith D, Clements M, Patel M, et al. Lower urinary tract symptoms in relation to region of birth in 95,393 men living in Australia: the 45 and Up Study. World J Urol. 2013;31(3):673–82. Epub 2012/09/04. 10.1007/s00345-012-0937-7 .
    1. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–14; discussion 14–5. Epub 2006/10/20. doi: S0302-2838(06)01116-X [pii] 10.1016/j.eururo.2006.09.019 .
    1. Kupelian V, Wei JT, O'Leary MP, Kusek JW, Litman HJ, Link CL, et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med. 2006;166(21):2381–7. Epub 2006/11/30. doi: 166/21/2381 [pii] 10.1001/archinte.166.21.2381 .
    1. Brenes GA. Age differences in the presentation of anxiety. Aging & mental health. 2006;10(3):298–302. Epub 2006/06/17. 10.1080/13607860500409898 .
    1. Fiske A, Wetherell JL, Gatz M. Depression in older adults. Annual review of clinical psychology. 2009;5:363–89. Epub 2009/03/31. 10.1146/annurev.clinpsy.032408.153621
    1. Vogelzangs N, Beekman AT, de Jonge P, Penninx BW. Anxiety disorders and inflammation in a large adult cohort. Translational psychiatry. 2013;3:e249 Epub 2013/04/25. 10.1038/tp.2013.27
    1. Patel A. Review: the role of inflammation in depression. Psychiatria Danubina. 2013;25 Suppl 2:S216–23. Epub 2013/10/23. .
    1. Postolache TT, Langenberg P, Zimmerman SA, Lapidus M, Komarow H, McDonald JS, et al. Changes in Severity of Allergy and Anxiety Symptoms Are Positively Correlated in Patients with Recurrent Mood Disorders Who Are Exposed to Seasonal Peaks of Aeroallergens. International journal of child health and human development: IJCHD. 2008;1(3):313–22. Epub 2008/01/01.
    1. Prather AA, Rabinovitz M, Pollock BG, Lotrich FE. Cytokine-induced depression during IFN-alpha treatment: the role of IL–6 and sleep quality. Brain, behavior, and immunity. 2009;23(8):1109–16. Epub 2009/07/21. 10.1016/j.bbi.2009.07.001
    1. Freedland SJ, Aronson WJ. Invited commentary: Lower urinary tract symptoms and inflammation–-weighing the evidence. Am J Epidemiol. 2009;169(11):1291–3; discussion 4–5. Epub 2009/04/28. 10.1093/aje/kwp084 .
    1. Valkanova V, Ebmeier KP, Allan CL. CRP, IL–6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150(3):736–44. Epub 2013/07/23. 10.1016/j.jad.2013.06.004 .
    1. Salim S, Chugh G, Asghar M. Inflammation in anxiety. Advances in protein chemistry and structural biology. 2012;88:1–25. Epub 2012/07/21. 10.1016/B978-0-12-398314-5.00001-5 .
    1. O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. Journal of psychiatric research. 2007;41(3–4):326–31. Epub 2006/07/28. 10.1016/j.jpsychires.2006.05.013 .
    1. Pennanen L, van der Hart M, Yu L, Tecott LH. Impact of serotonin (5-HT)2C receptors on executive control processes. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2013;38(6):957–67. Epub 2013/01/11. 10.1038/npp.2012.258
    1. Brennan AM, Fargnoli JL, Williams CJ, Li T, Willett W, Kawachi I, et al. Phobic anxiety is associated with higher serum concentrations of adipokines and cytokines in women with diabetes. Diabetes Care. 2009;32(5):926–31. Epub 2009/02/19. 10.2337/dc08-1979
    1. St Sauver JL, Sarma AV, Jacobson DJ, McGree ME, Lieber MM, Girman CJ, et al. Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort. Am J Epidemiol. 2009;169(11):1281–90. Epub 2009/04/28. 10.1093/aje/kwp085

Source: PubMed

3
구독하다